
IRulya Therapeutics rose 25.4% from $31.73 to $39.78, ahead of the S&P 500's −2.8%. Its worst day was Oct 13 (−14.0%), and its low came Oct 13 at $27.87.
Oct 9, 2026 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
IRulya Therapeutics closed at its lowest level of the year, 12.2% below where the year started.
−14.0%, the year's worst day · S&P 500 0.0%
Where it ended: a close of $39.78 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 13, 2026 (EPS est. $-1.13).
Nothing in the past 12 months.
All IRLA earningsStory events cover the past 12 months · Times ET
Nothing in the past 12 months.
All IRLA analyst actionsNothing in the past 12 months.
All IRLA dividend historyNothing in the past 12 months.
All IRLA newsReplay the year: the line draws itself and stops at each of the 1 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for IRLA and SPY from Benzinga historical bars. Not investment advice.